Nephros Stock Odds of Future Stock Price Finishing Over 1.96
| NEPH Stock | USD 1.64 0.03 1.86% |
Nephros |
Nephros Target Price Odds to finish over 1.96
The tendency of Nephros Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 1.96 or more in 90 days |
| 1.64 | 90 days | 1.96 | near 1 |
Based on a normal probability distribution, the odds of Nephros to move over $ 1.96 or more in 90 days from now is near 1 (This Nephros probability density function shows the probability of Nephros Stock to fall within a particular range of prices over 90 days) . Probability of Nephros price to stay between its current price of $ 1.64 and $ 1.96 at the end of the 90-day period is about 35.64 .
Given the investment horizon of 90 days Nephros has a beta of 0.57. This indicates as returns on the market go up, Nephros average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Nephros will be expected to be much smaller as well. Additionally Nephros has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Nephros Price Density |
| Price |
Predictive Modules for Nephros
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nephros. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nephros Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nephros is not an exception. The market had few large corrections towards the Nephros' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nephros, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nephros within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | -0.13 |
Nephros Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nephros for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nephros can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nephros generated a negative expected return over the last 90 days | |
| Nephros may become a speculative penny stock | |
| Nephros has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 14.24 M. Net Loss for the year was (1.57 M) with profit before overhead, payroll, taxes, and interest of 4.73 M. | |
| Nephros has a poor financial position based on the latest SEC disclosures | |
| About 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Amron Arthur H of 4582 shares of Nephros subject to Rule 16b-3 |
Nephros Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nephros Stock often depends not only on the future outlook of the current and potential Nephros' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nephros' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.4 M | |
| Cash And Short Term Investments | 4.3 M |
Nephros Technical Analysis
Nephros' future price can be derived by breaking down and analyzing its technical indicators over time. Nephros Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nephros. In general, you should focus on analyzing Nephros Stock price patterns and their correlations with different microeconomic environments and drivers.
Nephros Predictive Forecast Models
Nephros' time-series forecasting models is one of many Nephros' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nephros' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Nephros
Checking the ongoing alerts about Nephros for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nephros help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nephros generated a negative expected return over the last 90 days | |
| Nephros may become a speculative penny stock | |
| Nephros has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 14.24 M. Net Loss for the year was (1.57 M) with profit before overhead, payroll, taxes, and interest of 4.73 M. | |
| Nephros has a poor financial position based on the latest SEC disclosures | |
| About 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Amron Arthur H of 4582 shares of Nephros subject to Rule 16b-3 |
Check out Nephros Backtesting, Nephros Valuation, Nephros Correlation, Nephros Hype Analysis, Nephros Volatility, Nephros History as well as Nephros Performance. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 1.313 | Quarterly Revenue Growth (0.08) | Return On Assets (0.08) | Return On Equity (0.16) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.